Objective: To evaluate the therapeutic effect of Chinese patent drug Shu Feng Huo Luo Pian (疏风活络片 Pill for Dispelling Wind and Activating Collaterals) for the treatment of osseous arthritis. Method: 50 cases of osseous arthritis were divided randomly into two groups, the Shu Feng Huo Luo Pian group (the experimental group), including 30 cases (aged 63.5±4 years), treated with 2 such pills, po, bid; and the control group, including 19 cases (aged 63±5 years), treated with Sulindac 0.2g, po, bid. The two groups were all supplemented by medication of calcium Caltrate D 0.6g, po, qd. The above-mentioned medications were administered for 2 courses, 2 weeks constituting a course. Result: The total effective rate of the experimental group evaluated by the doctors was 83.3%, and that evaluated by the patients was 90%, with mild side effects. Conclusion: Shu Feng Huo Luo Pian is an effective Chinese patent drug for treating osseous arthritis, with less and mild side effects. Osseous arthritis is characterized mainly by chronic arthralgia, ankylosis, and arthroncus accompanied with dysfunction of the joint. It affects predominantly the movable joints of the human body, such as the joint of the hip, knee, ankle, elbow, and finger. It is a commonly seen disease, which mostly affects the life activities of the aged people. Its morbidity rises along with age. X-ray mass survey has shown that the morbidity of this disease among people aged 15-24 years is about 10%, while that among people aged 55 years is about 80%1. As China is entering an aged society, due attention should be paid to this kind of disease. This article offers a clinical observation on the therapeutic effect of Shu Feng Huo Luo Pian (疏风活络片 Pill for Dispelling Wind and Activating Collaterals) for 50 cases of osseous arthritis as reported below.